Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

Cassava Sciences has faced a lot of scrutiny, with key figures resigning and the company settling an SEC penalty. Read what ...

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024$149.0 Million in Cash and Cash Equivalents at September 30, ...

A breath of fresh air and lush green fields, adorned with an array of dynamic plants exhibiting diverse biodiversity, ...

Juliet Oduor is the proprietor of Blossom Health Essentials which makes gluten-free cassava flour for consumers Her son's health challenges motivated her to look for safe and nutritious alternatives, ...

Cassava is a popular Dominican produce, especially amongst the indigenous Kalinago people, who have historically incorporated the tuber into their culture and diet. This year, a uniquely crafted ...

The suspicious man and woman exited the vehicle and walked into the cassava field. A local man ... who focuses on translating breakingThai news stories into English. With a background in field ...

In this article, we are going to take a look at where Cassava Sciences, Inc. (NASDAQ:SAVA) stands against other stocks discussed by Jim Cramer during the latest lightning round. On Tuesday ...